FDA Commissioner Speaks on Implementation of the 21st Century Cures Act
By

By
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb testified before the US House of Representatives’ Energy and Commerce Committee on November 30, 2017 about the agency’s implementation of the…

US Senate Holds Hearings on Proposed HHS Secretary Nominee
By

By
The US Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing relating to the confirmation of President Trump’s nominee for the US Department of Health and Human Services…

AMRI Doubles Bulk API Aseptic Manufacturing Capacity
By

By
AMRI, a contract research, development, and manufacturing organization, has more than doubled its current bulk active pharmaceutical ingredient (API) aseptic manufacturing capacity through the addition of a new multipurpose aseptic…

FDA Commissioner Outlines Actions for Improving Generic-Drug Review Process
By

By
At the US Food and Drug Administration’s (FDA) Generic Drug Science Day, FDA Commissioner Scott Gottlieb outlined the steps the agency is taking to improve the generic-drug review process, including…

EMA Issues Guidance on Post-Brexit Changes for Pharma Companies
By

By
The European Medicines Agency (EMA) has issued procedural guidance to help pharmaceutical companies prepare for the UK’s withdrawal from the European Union (EU). The guidance document outlines the practical and…

Avantor Completes $6.5-Billion Acquisition of VWR
By

By

Emergent Gets FDA OK For Smallpox Vaccine Mfg plant
By

By
The US Food and Drug Administration has approved the supplemental biologics license application for manufacturing ACAM2000, a small-pox vaccine, from Emergent BioSolutions, a specialty pharmaceutical company and contract manufacturer. The…

AstraZeneca, PhaseBio Partner
By

By
PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, has signed an exclusive, worldwide license agreement with MedImmune, the global biologics research and development arm…

GE Healthcare Acquires Bioprocessing Start-up
By

By
GE Healthcare has completed the acquisition of Puridify, a Stevenage, UK-headquartered bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify has collaborated with several biopharmaceutical…

Glenmark Cited by FDA for Indian Plant
By

By
Glenmark Pharmaceuticals, a Mumbai, India-headquartered pharmaceutical company, has received a Form 483 with seven cited observations from the US Food and Drug administration (FDA) for its manufacturing facility in Baddi,…